High-grade osteosarcoma treated with hemicortical resection and biological reconstruction

Journal of Surgical Oncology

Volumn 105, Issue 8, 2012, Pages 825-829

  Chen, Wei Ming ^a,b   Wu, Po Kuei ^b,c   Chen, Cheng Fong ^a,b   Chung, Lien Hsiang ^a,b   Liu, Chien Lin ^a,b   Chen, Tain Hsiung ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

OGS; surgical margin; wide excision

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; LIQUID NITROGEN; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL RECONSTRUCTION; BONE DEFECT; BONE GRAFT; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; HEMICORTICAL RESECTION; HIGH GRADE OSTEOSARCOMA; HUMAN; IRRADIATION; JOINT FUNCTION; KNEE; MALE; MECHANICAL FAILURE; MEDICAL SOCIETY; METASTASIS; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL TECHNIQUE; TIBIA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; BONE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM GRADING; OSTEOSARCOMA; PROGNOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 84861092918     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23005     Document Type: Article

References (25)

1. Tsuchiya H, Wan SL, Sakayama K, et al.: Reconstruction using an autograft containing tumour treated by liquid nitrogen. J Bone Joint Surg Br 2005; 87: 218-225. (Pubitemid 40278024)
2. Chen TH, Chen WM, Huang CK,: Reconstruction after intercalary resection of malignant bone tumours: Comparison between segmental allograft and extracorporeally-irradiated autograft. J Bone Joint Surg Br 2005; 87: 704-709. (Pubitemid 40711647)
3. Chen WM, Chen TH, Huang CK, et al.: Treatment of malignant bone tumours by extracorporeally irradiated autograft-prosthetic composite arthroplasty. J Bone Joint Surg Br 2002; 84: 1156-1161. (Pubitemid 35414416)
4. Deijkers RL, Bloem RM, Hogendoorn PC, et al.: Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours. J Bone Joint Surg Br 2002; 84: 1009-1014.
5. Hayashi K, Tsuchiya H, Yamamoto N, et al.: Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery. Int Orthop 2008; 32: 63-68. (Pubitemid 351170102)
6. Kanazawa Y, Tsuchiya H, Nonomura A, et al.: Intentional marginal excision of osteosarcoma of the proximal fibula to preserve limb function. J Orthop Sci 2003; 8: 757-761. (Pubitemid 38017660)
7. Tsuchiya H, Tomita K, Mori Y, et al.: Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 1999; 27-35. (Pubitemid 29066071)
8. Lewis VO, Gebhardt MC, Springfield DS,: Parosteal osteosarcoma of the posterior aspect of the distal part of the femur. Oncological and functional results following a new resection technique. J Bone Joint Surg Am 2000; 82-A: 1083-1088. (Pubitemid 30624965)
9. Bieling P, Rehan N, Winkler P, et al.: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996; 14: 848-858. (Pubitemid 26085530)
10. Shin KH, Moon SH, Suh JS, et al.: Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res 2000; 200-208.
11. Dyke JP, Panicek DM, Healey JH, et al.: Osteogenic and Ewing sarcomas: Estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 2003; 228: 271-278. (Pubitemid 36736103)
12. Friedlaender GE,: Bone-banking. J Bone Joint Surg Am 1982; 64: 307-311.
13. Hsu RW, Wood MB, Sim FH, et al.: Free vascularised fibular grafting for reconstruction after tumour resection. J Bone Joint Surg Br 1997; 79: 36-42.
14. Trovik CS, Bauer HC,: Local recurrence of soft tissue sarcoma a risk factor for late metastases. 379 patients followed for 0.5-20 years. Acta Orthop Scand 1994; 65: 553-558.
15. Choong PF, Gustafson P, Willen H, et al.: Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumour characteristics. Int J Cancer 1995; 60: 33-37.
16. Coindre JM, Terrier P, Bui NB, et al.: Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14: 869-877. (Pubitemid 26085532)
17. Jeon DG, Lee SY, Kim JW,: Bone primary sarcomas undergone unplanned intralesional procedures-The possibility of limb salvage and their oncologic results. J Surg Oncol 2006; 94: 592-598.
18. Trovik CS, Bauer HC, Alvegard TA, et al.: Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000; 36: 710-716. (Pubitemid 30179741)
19. Enneking WF, Spanier SS, Malawer MM,: The effect of the Anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer 1981; 47: 1005-1022. (Pubitemid 11135929)
20. Wu PK, Chen WM, Chen CF, et al.: Primary osteogenic sarcoma with pulmonary metastasis. Clinical results and prognostic factors in 91 patients. Jpn J Clin Oncol 2009; 39: 514-522.
21. Meyers PA, Schwartz CL, Krailo M, et al.: Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005; 23: 2004-2011. (Pubitemid 46211380)
22. Smeland S, Muller C, Alvegard TA, et al.: Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: Prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39: 488-494. (Pubitemid 36173693)
23. Muscolo DL, Ayerza MA, Aponte-Tinao LA, et al.: Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee. J Bone Joint Surg Am 2005; 87: 226-236. (Pubitemid 41279112)
24. Kaste SC, Liu T, Billups CA, et al.: Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer 2004; 43: 723-728. (Pubitemid 39557707)
25. Kim MS, Lee SY, Cho WH, et al.: An examination of the efficacy of the 8cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients. J Surg Oncol 2008; 98: 427-431.